• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

南美洲的心力衰竭

Heart failure in South America.

作者信息

Bocchi Edimar Alcides

机构信息

Heart Institute, São Paulo University Medical School, Brazil.

出版信息

Curr Cardiol Rev. 2013 May;9(2):147-56. doi: 10.2174/1573403x11309020007.

DOI:10.2174/1573403x11309020007
PMID:23597301
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3682398/
Abstract

Continued assessment of temporal trends in mortality and epidemiology of specific heart failure in South America is needed to provide a scientific basis for rational allocation of the limited health care resources, and strategies to reduce risk and predict the future burden of heart failure. The epidemiology of heart failure in South America was reviewed. Heart failure is the main cause of hospitalization based on available data from approximately 50% of the South American population. The main etiologies of heart failure are ischemic, idiopathic dilated cardiomyopathy, valvular, hypertensive and chagasic etiologies. In endemic areas, Chagas heart disease may be responsible by 41% of the HF cases. Also, heart failure presents high mortality especially in patients with Chagas etiology. Heart failure and etiologies associated with heart failure may be responsible for 6.3% of causes of deaths. Rheumatic fever is the leading cause of valvular heart disease. However, a tendency to reduction of HF mortality due to Chagas heart disease from 1985 to 2006, and reduction in mortality due to HF from 1999 to 2005 were observed in selected states in Brazil. The findings have important public health implications because the allocation of health care resources, and strategies to reduce risk of heart failure should also consider the control of neglected Chagas disease and rheumatic fever in South American countries.

摘要

需要持续评估南美洲特定心力衰竭的死亡率和流行病学的时间趋势,以便为合理分配有限的医疗资源提供科学依据,并制定降低风险和预测未来心力衰竭负担的策略。本文对南美洲心力衰竭的流行病学进行了综述。根据来自约50%南美洲人口的现有数据,心力衰竭是住院的主要原因。心力衰竭的主要病因包括缺血性、特发性扩张型心肌病、瓣膜性、高血压性和恰加斯病因。在流行地区,恰加斯心脏病可能导致41%的心力衰竭病例。此外,心力衰竭的死亡率很高,尤其是由恰加斯病因引起的患者。心力衰竭及与心力衰竭相关的病因可能占死亡原因的6.3%。风湿热是瓣膜性心脏病的主要原因。然而,在巴西的一些选定州,观察到1985年至2006年期间恰加斯心脏病导致的心力衰竭死亡率呈下降趋势,以及1999年至2005年期间心力衰竭死亡率的下降。这些发现具有重要的公共卫生意义,因为医疗资源的分配以及降低心力衰竭风险的策略也应考虑到南美洲国家对被忽视的恰加斯病和风湿热的控制。

相似文献

1
Heart failure in South America.南美洲的心力衰竭
Curr Cardiol Rev. 2013 May;9(2):147-56. doi: 10.2174/1573403x11309020007.
2
Cardiomyopathy, adult valve disease and heart failure in South America.南美洲的心肌病、成人瓣膜病和心力衰竭。
Heart. 2009 Mar;95(3):181-9. doi: 10.1136/hrt.2008.151225. Epub 2008 Oct 31.
3
The reality of heart failure in Latin America.拉丁美洲心力衰竭的现状。
J Am Coll Cardiol. 2013 Sep 10;62(11):949-58. doi: 10.1016/j.jacc.2013.06.013. Epub 2013 Jul 10.
4
Contemporary Characteristics and Outcomes in Chagasic Heart Failure Compared With Other Nonischemic and Ischemic Cardiomyopathy.恰加斯病性心力衰竭与其他非缺血性和缺血性心肌病的当代特征及预后比较。
Circ Heart Fail. 2017 Nov;10(11). doi: 10.1161/CIRCHEARTFAILURE.117.004361.
5
Etiology of Heart Failure and Outcomes in Patients Hospitalized for Acute Decompensated Heart Failure With Preserved or Reduced Ejection Fraction.射血分数保留或降低的急性失代偿性心力衰竭住院患者的心力衰竭病因及预后
Am J Cardiol. 2016 Dec 15;118(12):1881-1887. doi: 10.1016/j.amjcard.2016.08.080. Epub 2016 Sep 15.
6
The epidemiological features of heart failure in developing countries: a review of the literature.发展中国家心力衰竭的流行病学特征:文献综述
Int J Cardiol. 2001 Sep-Oct;80(2-3):213-9. doi: 10.1016/s0167-5273(01)00497-1.
7
Isolated left ventricular noncompaction as a cause for heart failure and heart transplantation: a single center experience.孤立性左心室心肌致密化不全作为心力衰竭和心脏移植的病因:单中心经验
Cardiology. 2009;112(2):158-64. doi: 10.1159/000147899. Epub 2008 Jul 25.
8
Risk stratification in a Brazilian hospital-based cohort of 1220 outpatients with heart failure: role of Chagas' heart disease.巴西一家医院的1220名门诊心力衰竭患者队列中的风险分层:恰加斯心脏病的作用。
Int J Cardiol. 2005 Jul 10;102(2):239-47. doi: 10.1016/j.ijcard.2004.05.025.
9
Outcomes and Effect of Treatment According to Etiology in HFrEF: An Analysis of PARADIGM-HF.射血分数降低心衰(HFrEF)患者按病因的治疗结局和效果:PARADIGM-HF 分析。
JACC Heart Fail. 2019 Jun;7(6):457-465. doi: 10.1016/j.jchf.2019.02.015. Epub 2019 May 8.
10
Muscle mass, muscle strength, and functional capacity in patients with heart failure of Chagas disease and other aetiologies.恰加斯病和其他病因所致心力衰竭患者的肌肉质量、肌肉力量和功能能力
ESC Heart Fail. 2020 Oct;7(5):3086-3094. doi: 10.1002/ehf2.12936. Epub 2020 Aug 28.

引用本文的文献

1
Characterization of 2,500 Patients with Heart Failure and Analysis of Their Optimal Medical Therapy: Insights from the AMERICCAASS Registry.2500例心力衰竭患者的特征分析及其最佳药物治疗方案:来自AMERICCAASS注册研究的见解
Glob Heart. 2025 Mar 11;20(1):27. doi: 10.5334/gh.1418. eCollection 2025.
2
Unveiling the Group A Streptococcus Vaccine-Based L-Rhamnose from Backbone of Group A Carbohydrate: Current Insight Against Acute Rheumatic Fever to Reduce the Global Burden of Rheumatic Heart Disease.从A群碳水化合物主链中揭示基于A群链球菌疫苗的L-鼠李糖:当前对急性风湿热的认识,以减轻风湿性心脏病的全球负担。
F1000Res. 2025 Jan 30;13:132. doi: 10.12688/f1000research.144903.3. eCollection 2024.
3
Dapagliflozin for the treatment of heart failure with reduced ejection fraction in Brazil: a cost-effectiveness analysis.达格列净用于治疗巴西射血分数降低的心力衰竭:一项成本效益分析。
Lancet Reg Health Am. 2024 Dec 28;42:100968. doi: 10.1016/j.lana.2024.100968. eCollection 2025 Feb.
4
Cardiovascular Statistics - Brazil 2023.心血管统计数据 - 巴西2023年
Arq Bras Cardiol. 2024 Feb;121(2):e20240079. doi: 10.36660/abc.20240079.
5
[Latin American research in heart failure: visual and bibliometric analysis of the last 20 years].[拉丁美洲心力衰竭研究:过去20年的可视化与文献计量分析]
Arch Peru Cardiol Cir Cardiovasc. 2023 Dec 27;4(4):141-150. doi: 10.47487/apcyccv.v4i4.328. eCollection 2023 Oct-Dec.
6
Antitrypanosomal Activity of 1,2,3-Triazole-Based Hybrids Evaluated Using In Vitro Preclinical Translational Models.使用体外临床前转化模型评估基于1,2,3-三唑的杂化物的抗锥虫活性。
Biology (Basel). 2023 Sep 8;12(9):1222. doi: 10.3390/biology12091222.
7
Hypertrophic Cardiomyopathy in a Latin American Center: A Single Center Observational Study.拉丁美洲某中心的肥厚型心肌病:一项单中心观察性研究
J Clin Med. 2023 Aug 31;12(17):5682. doi: 10.3390/jcm12175682.
8
Prevalence of Neutralizing Antibodies against Adeno-Associated Virus Serotypes 1, 2, and 9 in Non-Injected Latin American Patients with Heart Failure-ANVIAS Study.未接受注射治疗的拉丁美洲心力衰竭患者中针对腺相关病毒血清型 1、2 和 9 的中和抗体流行率-ANVIAS 研究。
Int J Mol Sci. 2023 Mar 14;24(6):5579. doi: 10.3390/ijms24065579.
9
Development and Validation of a Nomogram Model for Predicting the Risk of Readmission in Patients with Heart Failure with Reduced Ejection Fraction within 1 Year.构建并验证 1 年内射血分数降低的心力衰竭患者再入院风险的列线图模型
Cardiovasc Ther. 2022 Sep 16;2022:4143173. doi: 10.1155/2022/4143173. eCollection 2022.
10
The Function, Role and Process of DDX58 in Heart Failure and Human Cancers.DDX58在心力衰竭和人类癌症中的功能、作用及过程
Front Oncol. 2022 Jun 22;12:911309. doi: 10.3389/fonc.2022.911309. eCollection 2022.

本文引用的文献

1
Impact of noncardiac comorbidities on morbidity and mortality in a predominantly male population with heart failure and preserved versus reduced ejection fraction.非心脏合并症对射血分数保留与降低的心衰患者(主要为男性)发病率和死亡率的影响。
J Am Coll Cardiol. 2012 Mar 13;59(11):998-1005. doi: 10.1016/j.jacc.2011.11.040.
2
[Updating of the Brazilian guideline for chronic heart failure - 2012].[《巴西慢性心力衰竭指南(2012年版)》的更新]
Arq Bras Cardiol. 2012 Jan;98(1 Suppl 1):1-33. doi: 10.1590/s0066-782x2012001000001.
3
Hospitalization and mortality rates for heart failure in public hospitals in São Paulo.圣保罗公立医院心力衰竭患者的住院率和死亡率。
Arq Bras Cardiol. 2011 Nov;97(5):402-7. doi: 10.1590/s0066-782x2011005000096. Epub 2011 Oct 7.
4
Hospitalizations for heart failure in the United States--a sign of hope.美国心力衰竭住院情况——希望的迹象。
JAMA. 2011 Oct 19;306(15):1705-6. doi: 10.1001/jama.2011.1510.
5
National and regional trends in heart failure hospitalization and mortality rates for Medicare beneficiaries, 1998-2008.1998-2008 年,医疗保险受益人心力衰竭住院率和死亡率的国家和地区趋势。
JAMA. 2011 Oct 19;306(15):1669-78. doi: 10.1001/jama.2011.1474.
6
[I Latin American guidelines for the diagnosis and treatment of Chagas cardiomyopathy].[《拉丁美洲恰加斯心肌病诊断与治疗指南》]
Arq Bras Cardiol. 2011;97(2 Suppl 3):1-48.
7
Education and telephone monitoring by nurses of patients with heart failure: randomized clinical trial.护士对心力衰竭患者的教育和电话监测:随机临床试验。
Arq Bras Cardiol. 2011 Mar;96(3):233-9. doi: 10.1590/s0066-782x2011005000014. Epub 2011 Feb 4.
8
Study of pro-thrombotic and pro-inflammatory factors in Chagas cardiomyopathy.探讨恰加斯心肌病的促血栓形成和促炎因子。
Arq Bras Cardiol. 2010 Oct;95(5):655-62. doi: 10.1590/s0066-782x2010005000146. Epub 2010 Nov 12.
9
Epidemiological, clinical e therapeutic profile of heart failure in a tertiary hospital.三级医院心力衰竭的流行病学、临床和治疗特征。
Arq Bras Cardiol. 2010 Sep;95(3):392-8. doi: 10.1590/s0066-782x2010005000102. Epub 2010 Aug 6.
10
Antitrypanosomal agents: treatment or threat?抗锥虫药物:是治疗手段还是威胁?
Lancet. 2010 Sep 4;376(9743):768; author reply 768-9. doi: 10.1016/S0140-6736(10)61372-4.